Maryland Commission for Women - Maryland Collaborative to Advance Implementation of Coverage of Over-the-Counter Birth Control
HB 939 requires the Maryland Commission for Women to establish a collaborative group focused on improving access to over-the-counter birth control. The collaborative, including representatives from health departments, insurance, pharmacies, reproductive health organizations, and consumer groups, will study and recommend ways to implement existing coverage requirements. Specifically, it will examine pharmacy coverage, point-of-sale options, public health initiatives for underserved individuals, and consumer education to enhance access for Maryland residents who currently face barriers to obtaining over-the-counter birth control.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2025
Committee Review
Mar 2025
House of Delegates Passage
Apr 2025
Senate Passage
Apr 2025
Signed into Law
May 2025
Introduced Jan 31, 2025
Signed May 6, 2025
Maddy AI version diff · 1 comparison
What changed between versions
First - Maryland Commission for Women - Maryland Collaborative to Advance Implementation of Coverage of Over-the-Counter Birth Control
→
Third - Maryland Commission for Women - Maryland Collaborative to Advance Implementation of Coverage of Over-the-Counter Birth Control
·
3 edits
MINOR
The bill was amended to add new sponsors and include procedural updates like committee approval and adoption dates. The substantive text of the bill regarding the establishment of the Collaborative and its members remains largely unchanged, with only minor formatting adjustments.
Scope change
No substantive change to the bill's scope or applicability; the legislative body and purpose remain the same.
TECHNICAL
Added new sponsors (Delegates Bhandari, Guzzone, Hill, S. Johnson, Kaiser, Kerr, Lopez, Martinez, Rosenberg, Taveras, White Holland, Woods, and Woorman) to the bill's sponsor list.
Added procedural notes indicating the bill was reported favorably by the committee, adopted by the House, and read for the second time on February 25, 2025.
Minor formatting changes to the bill header and explanatory notes regarding amendments.
Floor votes · Senate Mar 15, 2025 · House of Delegates Feb 27, 2025
How they voted
32–13
Passed · 1 other
Total votes 46
Mar 15, 2025
D
Democratic33
93% Yea
R
Republican13
92% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
15
Key actions
10
Committee
6
May 6, 2025
Signed into law
Approved by the Governor - Chapter 294
executive
Apr 2, 2025
Lower · Passed
Returned Passed
lower
Apr 2, 2025
Upper · Passed
Third Reading Passed
upper
Mar 28, 2025
Upper · Passed
Favorable Adopted
upper
Mar 27, 2025
Upper · Passed
Favorable Report by Finance
upper
Mar 15, 2025
Senate · Passed
Senate Vote: pass (32-13-1)
senate
Mar 7, 2025
Committee
Referred Finance
upper
Mar 6, 2025
Lower · Passed
Third Reading Passed
lower
Mar 4, 2025
Lower · Passed
Favorable with Amendments {
lower
Mar 3, 2025
Lower · Passed
Favorable with Amendments Report by Health and Government Operations
lower
Feb 27, 2025
House Of Delegates · Passed
House of Delegates Vote: pass (100-34-5)
house of delegates
Jan 31, 2025
Committee
First Reading Health and Government Operations
lower
17 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Anne Kaiser
DDemocratic
P
Bonnie Cullison
DDemocratic
P
Deni Taveras
DDemocratic
P
Gabriel Acevero
DDemocratic
P
Harry Bhandari
DDemocratic
P
Heather Bagnall Tudball
DDemocratic
P
Jamila Woods
DDemocratic
P
Jen Terrasa
DDemocratic
P
Jennifer White Holland
DDemocratic
P
JP
Joseline Peña-Melnyk
DDemocratic
P
Ken Kerr
DDemocratic
P
Lesley Lopez
DDemocratic
P
Pam Guzzone
DDemocratic
P
Sandy Rosenberg
DDemocratic
P
Steve Johnson
DDemocratic
P
Teresa Woorman
DDemocratic
P
Terri Hill
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 939
Scope: MD
Hi! I can help you understand HB 939. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline